InfuSystem Holdings, Inc.

INFU

US45685K1025

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 03:32:17 2024-05-21 pm EDT			5-day change	1st Jan Change
6.73 ^USD	+3.70%		-2.76%	-36.43%

May. 20	InfuSystem Approves $20 Million Share Buyback Plan -- Shares Rise After Hours	MT
May. 20	Tranche Update on InfuSystem Holdings, Inc.'s Equity Buyback Plan announced on June 30, 2021.	CI

Infusystem Holdings Inc. Re-Affirms Annual Earnings Guidance for the Year 2021

November 15, 2021 at 06:33 am EST

InfuSystem is reaffirming its annual earnings guidance for the full year 2021 with net revenues estimated to come in at the lower end of the range of $107.0 million to $110.0 million.

Latest news about InfuSystem Holdings, Inc.

InfuSystem Approves $20 Million Share Buyback Plan -- Shares Rise After Hours	May. 20	MT
Tranche Update on InfuSystem Holdings, Inc.'s Equity Buyback Plan announced on June 30, 2021.	May. 20	CI
InfuSystem Holdings, Inc. announces an Equity Buyback for $20 million worth of its shares.	May. 20	CI
InfuSystem Holdings, Inc.'s Equity Buyback announced on May 20, 2024, has expired with 553,149 shares, representing 2.67% for $6.16 million.	May. 19	CI
InfuSystem Holdings Inc. authorizes a Buyback Plan.	May. 19	CI
InfuSystem Holdings, Inc. Approves Directorate Elections	May. 17	CI
Transcript : InfuSystem Holdings, Inc. - Shareholder/Analyst Call	May. 16
Transcript : InfuSystem Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
InfuSystem Holdings, Inc. Reaffirms Earnings Guidance for the Full Year 2024	May. 09	CI
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Posts Q1 Revenue $32M	May. 09	MT
InfuSystem Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Gregg Lehman Not to Stand for Re-Election as Director of InfuSystem Holdings, Inc	Apr. 10	CI
Transcript : InfuSystem Holdings, Inc., Q4 2023 Earnings Call, Mar 14, 2024	Mar. 14
Infusystem Announces Operational And Financial Results For Q4 And FY 2023	Mar. 14	RE
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Reports Q4 Revenue $31.8M	Mar. 14	MT
InfuSystem Holdings, Inc. Provides Earnings Guidance for the Full Year 2024	Mar. 14	CI
InfuSystem Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
InfuSystem Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 14	CI
InfuSystem Holdings, Inc. Announces Resignation of R. Rimmy Malhotra as Member of the Board	Mar. 08	CI
Tranche Update on InfuSystem Holdings, Inc.'s Equity Buyback Plan announced on June 30, 2021.	Nov. 09	CI
Transcript : InfuSystem Holdings, Inc., Q3 2023 Earnings Call, Nov 07, 2023	Nov. 07
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Reports Q3 Revenue $31.9M	Nov. 07	MT
InfuSystem Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
InfuSystem Holdings, Inc. Provides Revenue Guidance for the Fourth Quarter of 2023	Nov. 07	CI
InfuSystem Holdings, Inc. Raises Earnings Guidance for the Full Year 2023	Nov. 07	CI

Chart InfuSystem Holdings, Inc.

Duration

Period

More charts

InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segmentâs core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-14 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for InfuSystem Holdings, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.49 USD

Average target price

14.83 USD

Spread / Average Target

+128.56%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
INFUSYSTEM HOLDINGS, INC.	-36.43%	138M
ABBOTT LABORATORIES	-6.50%	180B
MEDTRONIC PLC	+3.46%	112B
BECTON, DICKINSON AND COMPANY	-3.91%	68.53B
DEXCOM, INC.	+5.59%	51.97B
CENCORA, INC.	+5.77%	44.08B
HOYA CORPORATION	+5.62%	42.23B
METTLER-TOLEDO INTERNATIONAL, INC.	+24.61%	32.43B
TERUMO CORPORATION	+16.72%	26.39B
WEST PHARMACEUTICAL SERVICES, INC.	-3.93%	24.97B

Other Medical Equipment, Supplies & Distribution